You are on Trendlyne United States. Click here to go to India website or make United States as your default
  1. MARKETS
  2. SECTOR : HEALTHCARE EQUIPMENT & SUPPLIES
  3. INDUSTRY : MEDICAL SPECIALTIES
  4. PREDICTIVE ONCOLOGY INC

Predictive Oncology Inc XNAS: POAI

Predictive Oncology Inc Live Share Price Today, Share Analysis and Chart

Download real time

1.16 0.04 (3.57%)

62.09% Fall from 52W High

54,539 XNAS Volume

XNAS 17 Mar, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Share
Board Meeting
The next board meeting for Predictive Oncology Inc is on 28 Mar 2025 for the purpose of Predictive Oncology Inc Annual Report for 2024 See details

Predictive Oncology Inc Key Metrics

Select

Market Capitalization

Low in industry
8.4

PE TTM

Negative PE TTM
-0.6

Price to Book

Below industry Median
4.3

Institutional holding current Qtr %

Low in industry
3.7

Revenue Growth Qtr YoY %

Negative Revenue Growth Qtr YoY %
-48.9

Operating Revenue growth TTM %

Negative Operating Revenue growth TTM %
-14.4

Net Profit Qtr Growth YoY %

Below industry Median
2.2

Net Profit TTM Growth %

Below industry Median
24.2

Operating Profit Margin Qtr %

Negative Operating Profit Margin Qtr %
-669.4

Operating Profit Margin TTM %

Negative Operating Profit Margin TTM %
-960.8

Piotroski Score

Below industry Median
2

Rel Perf vs Sector quarter%

60.5

ROE Annual %

Negative ROE Annual %
-93.1

RoA Annual %

Negative RoA Annual %
-69.7
All financials are in USD Million and price data in USD
VIEW MORE

16

S

6

W

1

O

2

T

SWOT Analysis

Check P/E Buy Sell Zone

This stock has negative PE


Predictive Oncology Inc Live Price Chart

Switch to TradingView
Fetching data ...

Forecaster - Analyst Share Price Target and Estimates

Revenue forecast

Created with Highcharts 7.2.2Dec '24Dec '25Dec '2601020515Actual RevenueAvg. Estimate

EPS forecast

Current EPS
-2.1
Avg. Estimate
-2.1
Low Estimate
-2.1
High Estimate
-2.1
Current EPS
Avg. Estimate

Consensus Recommendation

1 ANALYST Recommendations
HOLD

Created with Highcharts 7.2.21Hold

The consensus recommendation from 1 analyst for Predictive Oncology Inc is HOLD

Forecaster is a Premium Feature
You need to upgrade your subscription plan to access this feature
See what you get

Predictive Oncology Inc Stock Analysis

Predictive Oncology Inc stock analysis with key metrics, changes, and trends.

Predictive Oncology Inc MetricVALUECHANGE %TRENDANALYSIS
Annual Revenue$1.78 M1.57%negative

Annual Revenue fell 1.57%, in the last year to $1.78 M. Its sector's average revenue growth for the last fiscal year was 8.73%.

Annual Net Profit$13.98 M24.1%positive

Annual Net Profit rose 24.1% in the last year to $13.98 M. Its sector's average net profit growth for the last fiscal year was 3.62%.

Price to Earning Ratio-0.6-negative

Price to Earning Ratio is -0.6, which is negative.

Stock Price$1.16-56.06%negative

Stock Price fell 56.06% and underperformed its sector by 62.83% in the past year.

Quarterly Revenue$0.35 M48.91%negative

Quarterly Revenue fell 48.91% YoY to $0.35 M. Its sector's average revenue growth YoY for the quarter was 8.57%.

Quarterly Net profit$3.09 M2.17%positive

Quarterly Net profit rose 2.17% YoY to $3.09 M. Its sector's average net profit growth YoY for the quarter was 27.31%.

Debt to Equity Ratio0.35-positive

Debt to Equity Ratio of 0.35 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

Return on Equity(ROE)-93.11 %-93.11%negative

Return on Equity(ROE) for the last financial year was -93.11%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

Mutual Fund Holding3.72 %-0.15%negative

Mutual Fund Holding decreased by 0.15% in the last quarter to 3.72.

Promoter Share Holding8.80 %0%neutral

Promoter Share Holding stayed the same in the most recent quarter at 8.8%.

Institutional Holding3.70 %0.31%positive

Institutional Holding increased by 0.31% in the last quarter to 3.7.

VIEW LESS


Loading data..

Predictive Oncology Inc - Company Profile

What does Predictive Oncology Inc do?

Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.

Predictive Oncology Inc Management structure

All Gross Remunerations are in USD
Mr. Josh Blacher
Chief Financial Officer
-
2024
Gross Remuneration
Year
Dr. Pamela Bush, PhD
Chief Business Officer
-
2024
Gross Remuneration
Year

Predictive Oncology Inc Board of directors

All Gross Remunerations are in USD
Mr. Chuck Nuzum
Lead Independent Director
98.9 K
2023
Gross Remuneration
Year
Dr. Nancy Chung-Welch
Independent Director
76.67 K
2023
Gross Remuneration
Year
Dr. Veena Rao, PhD
Independent Director
73.34 K
2023
Gross Remuneration
Year
Mr. Gregory S. St.Clair, Sr
Independent Director
65.56 K
2023
Gross Remuneration
Year
Dr. Matthew J. Hawryluk, PhD
Independent Director
65.56 K
2023
Gross Remuneration
Year
Dr. Daniel E. Handley, M.S.,PhD
Independent Director
54.45 K
2023
Gross Remuneration
Year

Predictive Oncology Inc FAQ

How is Predictive Oncology Inc today?
Predictive Oncology Inc today is trading in the green, and is up by 3.57% at 1.16.
Predictive Oncology Inc is currently trading up 3.57% on an intraday basis. In the past week the stock rose 8.41%. stock has been up 61.11% in the past quarter and fell -56.06% in the past year. You can view this in the overview section.